Company: ZLAB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023411
Chunk: 30

Company: Zai Lab Ltd
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 30
---
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

4

Zai Lab Limited 

Unaudited Condensed Consolidated Statements of Shareholders’ Equity 

(in thousands of $, except for number of shares) 

Ordinary SharesAdditionalpaidin capitalAccumulateddeficitAccumulatedothercomprehensiveincomeTreasury StockTotalNumberofSharesAmountSharesAmountBalance at December 31, 20241,082,614,740 7 3,264,295 (2,453,083)50,515 (4,912,200)(20,836)840,898 Issuance of ordinary shares upon vesting of restricted shares137,540 00— — — — — Exercise of share options6,324,120 03,733 — — — — 3,733 Issuance cost of the follow-on public offering— — (28)— — — — (28)Share-based compensation— — 15,800 — — — — 15,800 Net loss— — — (48,438)— — — (48,438)Foreign currency translation— — — — (1,212)— — (1,212)Balance at March 31, 20251,089,076,400 7 3,283,800 (2,501,521)49,303 (4,912,200)(20,836)810,753 

Ordinary SharesAdditionalpaidin capitalAccumulateddeficitAccumulatedothercomprehensiveincomeTreasury StockTotalNumberofSharesAmountSharesAmountBalance at December 31, 2023977,151,270 6 2,975,302 (2,195,980)37,626 (4,912,200)(20,836)796,118 Issuance of ordinary shares upon vesting of restricted shares1,046,440 00— — — — — Share-based compensation— — 17,980 — — — — 17,980 Net loss— — — (53,471)— — — (53,471)Foreign currency translation— — — — 1,542 — — 1,542 Balance at March 31